| Neurological complications after thrombolytic treatment for acute myocardial infarction: emphasis on unprecedented manifestations. | |
| | |
MedLine Citation:
|
PMID: 1621495 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We examined 348 patients who underwent thrombolytic treatment for acute myocardial infarction. Nine patients (2.58%) developed neurological complications related directly or indirectly to this procedure. Cerebral hemorrhage occurred in 3 patients; 2 patients had transient ischemic attacks, 1 had syncope, another had psychomotor agitation and 2 patients presented seizures during the infusion of the thrombolytic agent, without hemodynamic abnormalities. This latter feature had never been described before. |
| | |
Authors:
|
P Caramelli; E G Mutarelli; B Caramelli; B Tranchesi; F Pileggi; M Scaff |
Related Documents
:
|
8085435 - Co-localization of beta/a4 and cystatin c in cortical blood vessels in dutch, but not i... 18978245 - Mimicking of cerebral herniation through gamma-hydroxybutyric acid therapy. 9493895 - Enhanced erythrocyte aggregability in neurosurgical interventions carried out with mann... 9191775 - Barbiturate coma in severe hemispheric stroke: useful or obsolete? 6734645 - Prevalence of vasospastic ischaemia induced by the cold pressor test or hyperventilatio... 3383945 - High-dose ketoconazole to untreated stage d prostate cancer. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Acta neurologica Scandinavica Volume: 85 ISSN: 0001-6314 ISO Abbreviation: Acta Neurol. Scand. Publication Date: 1992 May |
Date Detail:
|
Created Date: 1992-08-06 Completed Date: 1992-08-06 Revised Date: 2006-08-16 |
Medline Journal Info:
|
Nlm Unique ID: 0370336 Medline TA: Acta Neurol Scand Country: DENMARK |
Other Details:
|
Languages: eng Pagination: 331-3 Citation Subset: IM |
Affiliation:
|
Department of Neurology, University of São Paulo, Brazil. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Brain Diseases / drug therapy, etiology, physiopathology Cerebrovascular Disorders / drug therapy, etiology Enzyme Activation Female Fibrinolytic Agents / diagnostic use* Heparin / administration & dosage, diagnostic use* Humans Male Middle Aged Myocardial Infarction / complications, physiopathology, therapy* Phenytoin / therapeutic use Seizures / drug therapy, etiology, physiopathology Thrombolytic Therapy* Tissue Plasminogen Activator / administration & dosage, diagnostic use* |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; 57-41-0/Phenytoin; 9005-49-6/Heparin; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Allelic heterogeneity in group A xeroderma pigmentosum.
Next Document: Effects of perineural opioids on nerve conduction of N. suralis in man.